By using WellRx, you accept our Privacy Policy (including the CA Privacy Act policy if you are a CA resident), including our collection of data and use of cookies.

SATRALIZUMAB (sat ra LIZ ue mab) treats neuromyelitis optica spectrum disorder (NMOSD), a condition that causes inflammation in the nerves of the eyes and spinal cord. It works by decreasing inflammation. It is a monoclonal antibody.


There are no images available for this medication.